Roivant Sciences (ROIV) Equity Ratio (2021 - 2026)

Roivant Sciences has reported Equity Ratio for 6 years, with the latest figure at 0.93 in Q1 2026.

• For the quarter ending Q1 2026, Equity Ratio rose 7.53% year-over-year to 0.93; the trailing twelve-month figure through Mar 2026 stood at 0.93 (up 7.53% YoY), and the FY2026 full-year result was 0.93, up 7.53% from the prior year.
• Equity Ratio for Q1 2026 stood at 0.93, down from 0.95 in the prior quarter.
• The five-year high for Equity Ratio was 0.96 in Q2 2025, with the low at 0.62 in Q2 2023.
• Historically, Equity Ratio has averaged 0.82 across 5 years, with a median of 0.89 in 2024.
• Annual changes were most pronounced in 2022 — Equity Ratio dropped 19.3% — and 2024, when it surged 45.33%.
• Roivant Sciences' Equity Ratio stood at 0.65 in 2022, then surged by 38.99% to 0.9 in 2023, then grew by 6.14% to 0.96 in 2024, then dropped by 0.4% to 0.95 in 2025, then decreased by 2.61% to 0.93 in 2026.
• The last three Equity Ratio figures came in at 0.93 (Q1 2026), 0.95 (Q4 2025), and 0.95 (Q3 2025), per Business Quant data.